Alamo BioCenter and our resource partners are proud to support Cizzle Bio, Inc. in bringing the revolutionary CIZ1B Biomarker Test to the clinical market. With a 95% sensitivity rate, this lung cancer pre-screening test offers unmatched accuracy, paving the way for early detection and saving lives. Follow Alamo BioCenter and Cizzle Bio, Inc. for updates on this life-changing innovation! #Innovation #LungCancerAwareness #EarlyDetection #Biotech #CizzleBio #AlamoBioCenter #LifeSavingScience
Our CIZ1B Biomarker test offers a 95% sensitivity rate, bringing accuracy and peace of mind to early lung cancer detection. Learn how this innovative blood test is transforming early detection. #CizzleBio #EarlyDetection